JPRN-UMIN000011237已完成未知
The Relationship between the dose of Epoetin Beta Pegol for treatment of renal anemia and renal prognosis in CKD Patients - The Relationship between the dose of Epoetin Beta Pegol and renal prognosis in CKD Patients
Toda Central General Hospital0 个研究点目标入组 50 人开始时间: 2013年7月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Anemia for other reasons than the renal anemia: 1) Iron deficiency (Serum ferritin <100 ng/mL and transferrin saturation <20%) 2) Vitamin B12 deficiency 3) Folic acid deficiency 4) Apparent hemorrhagic lesion 5) hematologic disease (e.g. leukemia, malignant lymphoma, myelodysplastic syndrome, aplastic anemia) 6) Disease associated with chronic inflammation (e.g. rheumatoid arthritis, inflammatory bowel disease) 7) Under myelosuppressive therapy (immunosuppressive therapy, chemotherapy or radiotherapy) (2) Under treatment for malignansy and severe infection (3) Post renal transplant patient (4) Hypersensitivity to epoetin beta pegol (5) Pregnancy or lactating (6) eGFR <6.0 mL/min/1.73 m2
研究者
相似试验
尚未招募
不适用
The influence of administration of epoetin beta pegol (CERA) and saccharated ferric oxide on erythroferron and hepcidin of hemodialyzed patientsHemodialyzed patients with renal anemiaJPRN-UMIN000016552Hyogo College of Medicine50
已完成
不适用
Effect of the number of epoetin alpha injections on the hemoglobin level of anaemic patients eligible for elective orthopedic surgeryanemiaNL-OMON45498Sint Maartenskliniek45
已完成
不适用
A study on treatment switch to epoetin beta pegol in patients who do not respond well to erythropoietin preparatioRenal anemia in Hemodialysis patientsJPRN-UMIN000008091Faculty of medicine, University of Miyazaki5
进行中（未招募）
1 期
A randomised control trial of the use of Epoetin Beta in the treatment of Post Transplant Anaemia - Epoetin Beta in PTAPost Transplant AnaemiaMedDRA version: 8.1 Level: LLT Classification code 10002071 Term: Anaemia NOSEUCTR2006-003502-26-GBBarts and the London NHS Trust
未知
Unknown
Administration study for Epoetin Beta Pegol product to healthy Japanese adult malesot applicableJPRN-jRCT1080221926Mitsubishi chemical Medience Corporation3